CE FY2025 SEC EDGAR DEF 14A #156 of 168 in industry

Celanese Corp CEO pay ratio

The CEO earned $463K in FY2025 against median worker pay of $92,540 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-03-04
Industry
Chemicals & Pharmaceuticals
Industry rank
#156/168

Data updated August 2026

Subscribe to Celanese Corp CEO pay filing updates (RSS)

CEO-to-worker pay ratio
5:1
Below Average (Scale: 0–1000:1)
CEO pay
$463K
Median worker
$92,540

Answer first

Celanese Corp's FY2025 CEO total of $463K ranks #1283 of 1,423 complete filings; its 5:1 pay ratio ranks #1352. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $92,540. Industry placement uses the FY2025 SIC-28 peer cohort (# 156 of 168, 8th percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1283
$463K of 1,423 FY2025
Ratio rank
#1352
5:1 of 1,423
Industry pct
8th
among the lower quartile of industry peers by pay ratio

How Celanese Corp ranks nationally

Celanese Corp CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$462,700 10th percentile higher than 10% of 1,423 companies

$0–$2,500,000: 304 companies (21%). This entry sits in this band. $2,500,000–$5,000,000: 182 companies (13%). Above this entry. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Celanese Corp vs. Chemicals & Pharmaceuticals peers

CEO total pay ($463K) against pay ratio (5:1) for Celanese Corp (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both02072002.94144005.96216008.88288011.82.1:112.5:123:133.4:143.9:1CEO total payPay ratio (CEO : median worker)Celanese Corp, CEO total pay: 462700 · Pay ratio (CEO : median worker): 5:1Celanese CorpApogee Therapeutics, Inc., CEO total pay: 1416630 · Pay ratio (CEO : median worker): 5:1Apogee Therapeutics, Inc.Highwater Ethanol LLC, CEO total pay: 394644 · Pay ratio (CEO : median worker): 4:1Highwater Ethanol LLCViridian Therapeutics, Inc.\DE, CEO total pay: 6776249 · Pay ratio (CEO : median worker): 4:1Viridian Therapeutics, Inc.\DEAlzamend Neuro, Inc., CEO total pay: 130000 · Pay ratio (CEO : median worker): 6:1Alzamend Neuro, Inc.Edgewise Therapeutics, Inc., CEO total pay: 443614 · Pay ratio (CEO : median worker): 6:1Edgewise Therapeutics, Inc.
Celanese Corp vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Celanese Corp's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Celanese Corp

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
5:1
FY2025
vs prior FY
-2:1
from FY2024 7:1
CEO $ YoY
-24%
$463K latest
Filings shown
3
FY2022–2025
Celanese Corp CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $772K - $85,734 9:1 -
2024 $610K -21% $87,209 7:1 -2:1
2025 $463K -24% $92,540 5:1 -2:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1306830, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
5:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$463K
Companies in Industry
168
vs. Industry Median
Below
#156 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Celanese Corp: near-parity Item 402(u) ratio

Celanese Corp's FY2025 ratio 5:1 ranks #156 of 168 Chemicals & Pharmaceuticals filers (8th percentile). the CEO earned 5× the median employee ($92,540) in FY2025.

At $92,540 median worker pay, the FLOOR stamp is near pay-parity territory under MICRO CEO total.

CEO Total Pay

$463K

FY2025 Summary Compensation, below median

Pay Ratio

5:1

Below typical

Celanese Corp in the lower Chemicals & Pharmaceuticals third

Celanese Corp's FY2025 ratio 5:1 ranks #156 of 168 Chemicals & Pharmaceuticals filers (8th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Celanese Corp's $463K CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1283 and ratio rank #1352 split - treat 5:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$463K
Median Employee Pay
$92,540
Pay Ratio
5:1
Filing Date
2026-03-04

Company Info

Ticker
CE
CIK
1306830
Industry
Chemicals & Pharmaceuticals
SIC Code
2820
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1306830, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Celanese Corp's FY2025 ratio 5:1 ranks #156 of 168 Chemicals & Pharmaceuticals filers (8th percentile).

Read with Celanese Corp

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · MICRO · HIGH-MED.

Royal Gold Inc · MICRO

ABS(ceo_total_comp) peer at $467K (Δ $4K heavier vs Celanese Corp); FLOOR · ELITE-MED vs this page's FLOOR · MICRO · HIGH-MED.
Veeva Systems Inc · MICRO

ABS(ceo_total_comp) peer at $471K (Δ $8K heavier vs Celanese Corp); FLOOR · ELITE-MED vs this page's FLOOR · MICRO · HIGH-MED.
Telephone & Data Systems Inc /de/ · MICRO

ABS(ceo_total_comp) peer at $453K (Δ $10K lighter vs Celanese Corp); FLOOR · HIGH-MED vs this page's FLOOR · MICRO · HIGH-MED.
Oscar Health, Inc. · MICRO

ABS(ceo_total_comp) peer at $441K (Δ $22K lighter vs Celanese Corp); FLOOR · HIGH-MED vs this page's FLOOR · MICRO · HIGH-MED.
Apogee Therapeutics, Inc. (SIC 28 pole)

Apogee Therapeutics, Inc. stamps FLOOR · LIGHT nearest in-SIC by ABS(pay_ratio) to Celanese Corp's FLOOR filing.
National dual ranks · #1283/#1352

Celanese Corp's FY2025 package sits #1283 by CEO dollars and #1352 by ratio under MICRO · FLOOR.
Ratio primer · FLOOR

Celanese Corp's FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Celanese Corp (CIK 1306830), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.